Schwartz Investment Counsel’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Buy
60,800
+1,800
+3% +$97.7K 0.17% 79
2026
Q1
$2.28M Buy
59,000
+13,000
+28% +$540K 0.08% 96
2025
Q4
$2.14M Buy
+46,000
New +$2.22M 0.07% 100

Other funds holding HNGE

Schwartz Investment Counsel's HNGE Position: Q2 2026 in Review

Schwartz Investment Counsel increased its Hinge Health (HNGE) stake by 3.1% in Q2 2026, buying an estimated $97.7K and bringing the position to 60,800 shares worth $5.05M. The position accounts for 0.17% of the portfolio, ranked #79.

Schwartz Investment Counsel first reported a position in HNGE in Q4 2025 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Schwartz Investment Counsel held 60,800 shares of Hinge Health worth $5.05M as of Q2 2026.
  • Schwartz Investment Counsel bought 1,800 Hinge Health shares in Q2 2026, an estimated $97.7K.
  • Hinge Health made up 0.17% of Schwartz Investment Counsel's portfolio in Q2 2026, its #79 holding.
  • Schwartz Investment Counsel first reported a position in Hinge Health in Q4 2025 and has held it in 3 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Schwartz Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.